Prognostic Value of Residual Tumor Size in Patients With Epithelial Ovarian Cancer FIGO Stages IIA–IV: Analysis of the OVCAD Data
暂无分享,去创建一个
R. Zeillinger | I. Vergote | N. Concin | J. Sehouli | T. Van Gorp | S. Polterauer | L. Woelber | I. Braicu | S. Mahner | D. Castillo-Tong | R. Chekerov | I. Cadron | D. castillo-Tong | T. van Gorp
[1] D. Flum,et al. Thirty-Day Mortality After Primary Cytoreductive Surgery for Advanced Ovarian Cancer in the Elderly , 2011, Obstetrics and gynecology.
[2] I. Zapardiel,et al. New terminology for cytoreduction in advanced ovarian cancer. , 2011, The Lancet. Oncology.
[3] D. Levine,et al. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas. , 2010, Gynecologic oncology.
[4] G. Kenter,et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. , 2010, The New England journal of medicine.
[5] D. Chi,et al. The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm. , 2010, Gynecologic oncology.
[6] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[7] Jacobus Pfisterer,et al. Influence of Residual Tumor on Outcome in Ovarian Cancer Patients With FIGO Stage IV Disease , 2010, Annals of Surgical Oncology.
[8] Jacobus Pfisterer,et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials , 2009, Cancer.
[9] P. Sevelda,et al. Influence of Department Volume on Survival for Ovarian Cancer: Results From a Prospective Quality Assurance Program of the Austrian Association for Gynecologic Oncology , 2009, International Journal of Gynecologic Cancer.
[10] R. Barakat,et al. The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer. , 2008, Gynecologic oncology.
[11] M. Markman. Concept of optimal surgical cytoreduction in advanced ovarian cancer: a brief critique and a call for action. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Michelle L. Wynn,et al. Predictors of comprehensive surgical treatment in patients with ovarian cancer , 2007, Cancer.
[13] D. Levine,et al. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? , 2007, Gynecologic oncology.
[14] D. French,et al. Imiquimod treatment of vulvitis circumscripta plasmacellularis , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[15] Hys Ngan,et al. Carcinoma of the Ovary , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[16] G. Rustin,et al. Use of CA-125 to assess response to new agents in ovarian cancer trials. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] D. Chi,et al. Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment. , 2011, Gynecologic oncology.
[18] J. Dungan,et al. Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer , 2011 .
[19] S. Rubin,et al. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] P Maisonneuve,et al. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[21] E. Trimble,et al. Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis. , 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.